drugset / Trial / NCT02171676
BIBW 2992 After Administration of Docetaxel in Patients With Advanced Solid Tumors
RandomizedSingle-groupOpen-labelTreatment
Summary
Maximum tolerated dose (MTD), safety, pharmacokinetic and pharmacodynamic parameters, and efficacy of pulsatile administration of BIBW 2992 in combination with docetaxel (Taxotere®)
Timeline
- Start
- 2005-05
- Primary completion
- 2008-03
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Afatinib | Small molecule | — | — |
| Background | Docetaxel | Small molecule | — | — |